ISRO and DBT inked a pact to conduct biotechnology experiments in the space station.
The Indian Space Research Organisation (ISRO) and the Department of Biotechnology (DBT) have signed an agreement to design and conduct experiments at the Bharatiya Antariksh Station (BAS).
This agreement will promote innovation and developments in human health research, novel pharmaceuticals, biotherapeutics, and regenerative medicine.
Experiments including how weightlessness can influence muscle loss in those in space, what kind of algae may be suitable as nutrients or to preserve food for longer, etc. will be conducted.
The Bharatiya Antariksh Station (BAS) is a proposed indigenous space station to take shape from 2028-2035.
The ISRO-DBT also collaborated for another initiative called the BIOE3 (Biotechnology for Economy, Environment and Employment).
China launched the base module of its space station, Tiangong, in 2021 and has completed the tri-modular station as of November 2022.
